SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today announced interim results from the ongoing open-label KINECT ®-HD2 study about INGREZZA ® (valbenazine) ...
SAN DIEGO, Oct. 6, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today presented new data from the open-label KINECT ®-HD2 study demonstrating an established long-term safety ...
Data Reinforce the Clinically Meaningful Impact of INGREZZA in Adults with Huntington's Disease Chorea Findings Presented at the 2025 American Association of Neuroscience Nurses Neuroscience Advanced ...
SAN DIEGO -- Treatment with investigational pridopidine seemed to offer benefits for certain patients with Huntington's disease, according to subgroup analysis of the PROOF-HD trial. Those ...
A new medical trial showed promising results as scientists seek a breakthrough to treat Huntington's disease, according to research team based in the United Kingdom. The clinical drug trial by ...
Topline data showed that an investigational gene therapy slowed Huntington's disease progression and met its primary endpoint in a pivotal trial, uniQure Biopharma announced Wednesday. A high-dose ...
Woody Guthrie (1912–1967) was a well-known singer/songwriter with undiagnosed Huntington's disease (HD), born to a family burdened by undiagnosed HD. Guthrie’s mother, Nora, had the disease and was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results